Hormone receptor-related gene polymorphisms and prostate cancer risk in North Indian population

Khadijeh Onsory, R. C. Sobti, Adnan Issa Al-Badran, Masatoshi Watanabe, Taizo Shiraishi, Awtar Krishan, Harsh Mohan, Pushpinder Kaur

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

The purpose of this study was to analyse the frequency and type of mutations in the coding region of androgen receptor (AR) and to determine the role of polymorphisms in the intron 1 of ERα, exon 5 of ERβ, intron 7 of progesterone, exon 7 of the aromatase (CYP19) and exon 9 of VDR genes in the risk of prostate cancer. PCR-RFLP analysis of all above the genes was on 100 prostate cancer patients and an equal number of matching controls. The study also included PCR-SSCP analyses of exons 2-8 of AR gene. The genotype containing -/- allele of ERα gene was statistically significant for the risk of prostate cancer pose (OR, 2.70; 95% CI, 1.08-6.70, P = 0.032) Rr genotype of ERβ gene also have a higher risk (OR, 1.65; 95% CI, 0.52-5.23) for prostate cancer. The Cys allele of CYP19 gene was also associated with statistically significant increased risk of prostate cancer (OR; 2.28, 95% CI, 1.20-4.35, P = 0.012). tt genotype of codon 352 of VDR gene showed an OR of 0.43 for (95% CI, 0.13-1.39) and an OR for Tt genotype was 0.65 (95% CI, 0.36-1.16). Taken together, the results showed that in North Indian population, ERα and CYP19 genes may be playing a role in the risk of prostate cancer.

Original languageEnglish
Pages (from-to)25-35
Number of pages11
JournalMolecular and Cellular Biochemistry
Volume314
Issue number1-2
DOIs
StatePublished - Jul 1 2008
Externally publishedYes

Fingerprint

Polymorphism
Prostatic Neoplasms
Genes
Hormones
Aromatase
Population
Exons
Genotype
Androgen Receptors
Introns
Alleles
Single-Stranded Conformational Polymorphism
Polymerase Chain Reaction
Mutation Rate
Codon
Restriction Fragment Length Polymorphisms
Progesterone

Keywords

  • AR
  • CYP19
  • ERs
  • PR
  • Prostate carcinoma
  • VDR gene polymorphisms

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Molecular Biology
  • Genetics
  • Cell Biology

Cite this

Onsory, K., Sobti, R. C., Al-Badran, A. I., Watanabe, M., Shiraishi, T., Krishan, A., ... Kaur, P. (2008). Hormone receptor-related gene polymorphisms and prostate cancer risk in North Indian population. Molecular and Cellular Biochemistry, 314(1-2), 25-35. https://doi.org/10.1007/s11010-008-9761-1

Hormone receptor-related gene polymorphisms and prostate cancer risk in North Indian population. / Onsory, Khadijeh; Sobti, R. C.; Al-Badran, Adnan Issa; Watanabe, Masatoshi; Shiraishi, Taizo; Krishan, Awtar; Mohan, Harsh; Kaur, Pushpinder.

In: Molecular and Cellular Biochemistry, Vol. 314, No. 1-2, 01.07.2008, p. 25-35.

Research output: Contribution to journalArticle

Onsory, K, Sobti, RC, Al-Badran, AI, Watanabe, M, Shiraishi, T, Krishan, A, Mohan, H & Kaur, P 2008, 'Hormone receptor-related gene polymorphisms and prostate cancer risk in North Indian population', Molecular and Cellular Biochemistry, vol. 314, no. 1-2, pp. 25-35. https://doi.org/10.1007/s11010-008-9761-1
Onsory, Khadijeh ; Sobti, R. C. ; Al-Badran, Adnan Issa ; Watanabe, Masatoshi ; Shiraishi, Taizo ; Krishan, Awtar ; Mohan, Harsh ; Kaur, Pushpinder. / Hormone receptor-related gene polymorphisms and prostate cancer risk in North Indian population. In: Molecular and Cellular Biochemistry. 2008 ; Vol. 314, No. 1-2. pp. 25-35.
@article{86614db191ef4e9a9f54d59ac67e8164,
title = "Hormone receptor-related gene polymorphisms and prostate cancer risk in North Indian population",
abstract = "The purpose of this study was to analyse the frequency and type of mutations in the coding region of androgen receptor (AR) and to determine the role of polymorphisms in the intron 1 of ERα, exon 5 of ERβ, intron 7 of progesterone, exon 7 of the aromatase (CYP19) and exon 9 of VDR genes in the risk of prostate cancer. PCR-RFLP analysis of all above the genes was on 100 prostate cancer patients and an equal number of matching controls. The study also included PCR-SSCP analyses of exons 2-8 of AR gene. The genotype containing -/- allele of ERα gene was statistically significant for the risk of prostate cancer pose (OR, 2.70; 95{\%} CI, 1.08-6.70, P = 0.032) Rr genotype of ERβ gene also have a higher risk (OR, 1.65; 95{\%} CI, 0.52-5.23) for prostate cancer. The Cys allele of CYP19 gene was also associated with statistically significant increased risk of prostate cancer (OR; 2.28, 95{\%} CI, 1.20-4.35, P = 0.012). tt genotype of codon 352 of VDR gene showed an OR of 0.43 for (95{\%} CI, 0.13-1.39) and an OR for Tt genotype was 0.65 (95{\%} CI, 0.36-1.16). Taken together, the results showed that in North Indian population, ERα and CYP19 genes may be playing a role in the risk of prostate cancer.",
keywords = "AR, CYP19, ERs, PR, Prostate carcinoma, VDR gene polymorphisms",
author = "Khadijeh Onsory and Sobti, {R. C.} and Al-Badran, {Adnan Issa} and Masatoshi Watanabe and Taizo Shiraishi and Awtar Krishan and Harsh Mohan and Pushpinder Kaur",
year = "2008",
month = "7",
day = "1",
doi = "10.1007/s11010-008-9761-1",
language = "English",
volume = "314",
pages = "25--35",
journal = "Molecular and Cellular Biochemistry",
issn = "0300-8177",
publisher = "Springer Netherlands",
number = "1-2",

}

TY - JOUR

T1 - Hormone receptor-related gene polymorphisms and prostate cancer risk in North Indian population

AU - Onsory, Khadijeh

AU - Sobti, R. C.

AU - Al-Badran, Adnan Issa

AU - Watanabe, Masatoshi

AU - Shiraishi, Taizo

AU - Krishan, Awtar

AU - Mohan, Harsh

AU - Kaur, Pushpinder

PY - 2008/7/1

Y1 - 2008/7/1

N2 - The purpose of this study was to analyse the frequency and type of mutations in the coding region of androgen receptor (AR) and to determine the role of polymorphisms in the intron 1 of ERα, exon 5 of ERβ, intron 7 of progesterone, exon 7 of the aromatase (CYP19) and exon 9 of VDR genes in the risk of prostate cancer. PCR-RFLP analysis of all above the genes was on 100 prostate cancer patients and an equal number of matching controls. The study also included PCR-SSCP analyses of exons 2-8 of AR gene. The genotype containing -/- allele of ERα gene was statistically significant for the risk of prostate cancer pose (OR, 2.70; 95% CI, 1.08-6.70, P = 0.032) Rr genotype of ERβ gene also have a higher risk (OR, 1.65; 95% CI, 0.52-5.23) for prostate cancer. The Cys allele of CYP19 gene was also associated with statistically significant increased risk of prostate cancer (OR; 2.28, 95% CI, 1.20-4.35, P = 0.012). tt genotype of codon 352 of VDR gene showed an OR of 0.43 for (95% CI, 0.13-1.39) and an OR for Tt genotype was 0.65 (95% CI, 0.36-1.16). Taken together, the results showed that in North Indian population, ERα and CYP19 genes may be playing a role in the risk of prostate cancer.

AB - The purpose of this study was to analyse the frequency and type of mutations in the coding region of androgen receptor (AR) and to determine the role of polymorphisms in the intron 1 of ERα, exon 5 of ERβ, intron 7 of progesterone, exon 7 of the aromatase (CYP19) and exon 9 of VDR genes in the risk of prostate cancer. PCR-RFLP analysis of all above the genes was on 100 prostate cancer patients and an equal number of matching controls. The study also included PCR-SSCP analyses of exons 2-8 of AR gene. The genotype containing -/- allele of ERα gene was statistically significant for the risk of prostate cancer pose (OR, 2.70; 95% CI, 1.08-6.70, P = 0.032) Rr genotype of ERβ gene also have a higher risk (OR, 1.65; 95% CI, 0.52-5.23) for prostate cancer. The Cys allele of CYP19 gene was also associated with statistically significant increased risk of prostate cancer (OR; 2.28, 95% CI, 1.20-4.35, P = 0.012). tt genotype of codon 352 of VDR gene showed an OR of 0.43 for (95% CI, 0.13-1.39) and an OR for Tt genotype was 0.65 (95% CI, 0.36-1.16). Taken together, the results showed that in North Indian population, ERα and CYP19 genes may be playing a role in the risk of prostate cancer.

KW - AR

KW - CYP19

KW - ERs

KW - PR

KW - Prostate carcinoma

KW - VDR gene polymorphisms

UR - http://www.scopus.com/inward/record.url?scp=45449103057&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=45449103057&partnerID=8YFLogxK

U2 - 10.1007/s11010-008-9761-1

DO - 10.1007/s11010-008-9761-1

M3 - Article

C2 - 18483761

AN - SCOPUS:45449103057

VL - 314

SP - 25

EP - 35

JO - Molecular and Cellular Biochemistry

JF - Molecular and Cellular Biochemistry

SN - 0300-8177

IS - 1-2

ER -